Insider Transactions in Q4 2024 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
12,447
-1.65%
|
$24,894
$2.47 P/Share
|
|
Dec 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,234
-1.38%
|
$4,468
$2.43 P/Share
|
|
Dec 17
2024
|
Benjamin Halladay Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,245
-1.33%
|
$6,490
$2.42 P/Share
|
|
Nov 19
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
197
-0.12%
|
$394
$2.17 P/Share
|
|
Oct 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
107
-0.07%
|
$214
$2.12 P/Share
|